[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy

Research output: Contribution to journalArticlepeer-review


Background The purpose of our study was to analyze the role of [ 11C]choline-positron emission tomography/computed tomography (cho-PET/CT) in the management of patients with prostate cancer referred for radiotherapy. Patients and Methods Inclusion criteria for this retrospective study were (1) presence of prostate cancer, (2) referral for first radiotherapy course (for primary or recurrent tumor) between February 2007 and July 2010, and (3) performance of cho-PET/CT. All cho-PET/CT scans were classified according to whether they were positive in the prostate/prostate bed (T), pelvic lymph nodes (N), and distant metastases (M) or negative. Therapeutic strategy based on the cho-PET/CT evaluation was compared with the strategy that would have been proposed had cho-PET/CT imaging not been available, following international and national prostate cancer guidelines. Results Eighty-two cho-PET/CT scans performed in 74 patients were analyzed. Cho-PET/CT was positive in 49 studies (60%): T only in 22 (45% of all positive studies); N only in 4 (8%); T in combination with N in 3 (6%); and M in combination with T or N, or both, in 16 (33%). Treatment after positive cho-PET/CT examination included radiotherapy ± androgen deprivation (29 patients), surgery ± radiotherapy (6 patients), androgen deprivation only (8 patients), and other treatment (6 patients). In 22 cases, cho-PET/CT (27%) altered the treatment approach compared with the treatment that would have been adopted in the absence of cho-PET/CT analysis. Conclusion Cho-PET/CT is valuable in defining the extent of disease and supporting therapeutic decisions in the management of prostate cancer. The therapeutic strategy turned out to be influenced by cho-PET/CT imaging in about one third of the patients included in this study.

Original languageEnglish
Pages (from-to)155-159
Number of pages5
JournalClinical Genitourinary Cancer
Issue number3
Publication statusPublished - 2014


  • Choline PET
  • Prostate cancer
  • Radiotherapy
  • Recurrent tumor

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Medicine(all)


Dive into the research topics of '[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy'. Together they form a unique fingerprint.

Cite this